{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Ff9d7b552-ecd8-43d9-8643-30b0a0374b68","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/f9d7b552-ecd8-43d9-8643-30b0a0374b68\"></iframe>","title":"Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","description":"\n        <p>Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia, moderated by Dr Neil Love. Produced by Research To Practice. </p>\n\n<p>CME information and select publications <a href=\"https://www.researchtopractice.com/OncologyTodayPHPosALL24\" rel=\"nofollow\">here</a>. </p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/c29f3917-9ba4-4519-9853-049db8452c8d/cover.jpg"}